Science Explorer Back to mapMap
Discussion
Nonprofit · San Francisco · ??

Medicines360

Research works
3
▼ 41% vs 2018-21
Citations
74
22.2 per fractional work
Top-10% rate
65.7%
all institutions 10.0%
Open access
80%
world 40%

Not ranked overall: Medicines360 is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Medicines360 work in?

In all years, 88% of research at Medicines360 is in Health Sciences, 12% in Social Sciences. Its largest fields are Medicine (88%), Social Sciences (12%). It does 1.6× the world's share of Health Sciences.

Health Sciences88%Social Sciences12%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 2 fields, with their numbers
    1. Medicine387.9%
    1. Social Sciences012.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Medicines360?

The most cited paper from Medicines360 is "Clinicians' Perspectives on Racism and Black Women's Maternal Health" (Brittany D. Chambers, Brianne Taylor, Tamara Nelson et al., 2022), with 75 citations. Next come "Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system" (33) and "Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use" (28).

Most cited papers
#PaperReleasedCitations
1 Clinicians' Perspectives on Racism and Black Women's Maternal Health Brittany D. Chambers, Brianne Taylor, Tamara Nelson et al. · Women s Health Reports Open access May 2022 75
2 Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system Mitchell David Creinin, Rolf Jansen, Robert M. Starr et al. · Contraception Open access 30 Apr 2016 33
3 Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use Mitchell David Creinin, Courtney A. Schreiber, David Keith Turok et al. · American Journal of Obstetrics and Gynecology Open access 13 May 2022 28
4 Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use Philip D. Darney, Gretchen S. Stuart, Michael A. Thomas et al. · Contraception Open access 14 Oct 2017 27
5 Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States Alison B. Comfort, Lavanya Rao, Suzan Goodman et al. · Reproductive Health Open access 22 Apr 2022 24
All 17 most cited papers, with filters and sorting

Which research topics does Medicines360 publish most on?

By volume in 2022-now: Maternal and Perinatal Health Interventions, Reproductive Health and Contraception, Racial and Ethnic Identity Research and Cultural Competency in Health Care.

  1. 1 Maternal and Perinatal Health Interventions Obstetrics and Gynecology 0 works
  2. 2 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 0 works
  3. 3 Racial and Ethnic Identity Research Sociology and Political Science 0 works
  4. 4 Cultural Competency in Health Care Sociology and Political Science 0 works
  5. 5 COVID-19 Impact on Reproduction Obstetrics and Gynecology 0 works
  6. 6 Homicide, Infanticide, and Child Abuse Sociology and Political Science 0 works
  7. 7 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 0 works
  8. 8 Reproductive Health and Technologies Reproductive Medicine 0 works
  9. 9 Global Cancer Incidence and Screening Oncology 0 works
  10. 10 Cervical Cancer and HPV Research Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available79.7%not open20.3%

World: 40% of research is openly available.

How has Medicines360's research output changed?

Output in 2022-2025 was 41% lower than in 2018-2021.

2020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Medicines360. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.